|
LOC728640 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.764600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.244000E-01 |
| Normal-vs-Stage2 |
5.349600E-01 |
| Normal-vs-Stage3 |
7.796600E-01 |
| Normal-vs-Stage4 |
5.138600E-01 |
| Stage1-vs-Stage2 |
9.464200E-01 |
| Stage1-vs-Stage3 |
1.105390E-01 |
| Stage1-vs-Stage4 |
8.762800E-01 |
| Stage2-vs-Stage3 |
4.123400E-01 |
| Stage2-vs-Stage4 |
9.583200E-01 |
| Stage3-vs-Stage4 |
3.731800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.524400E-01 |
| Normal-vs-AfricanAmerican |
4.252800E-01 |
| Normal-vs-Asian |
3.021800E-01 |
| Caucasian-vs-AfricanAmerican |
7.658400E-01 |
| Caucasian-vs-Asian |
5.436800E-01 |
| AfricanAmerican-vs-Asian |
6.159000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.757200E-01 |
| Normal-vs-Female |
4.351700E-02 |
| Male-vs-Female |
1.167890E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.613200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.084610E-01 |
| Normal-vs-Age(61-80Yrs) |
8.833800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.370600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.500200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.193400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.210400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.854400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.454100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.114800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.464180E-02 |
| Normal-vs-Grade 2 |
6.065600E-02 |
| Normal-vs-Grade 3 |
5.197200E-01 |
| Normal-vs-Grade 4 |
7.070600E-01 |
| Grade 1-vs-Grade 2 |
2.914800E-01 |
| Grade 1-vs-Grade 3 |
4.117700E-03 |
| Grade 1-vs-Grade 4 |
6.579600E-02 |
| Grade 2-vs-Grade 3 |
1.981050E-03 |
| Grade 2-vs-Grade 4 |
3.260800E-01 |
| Grade 3-vs-Grade 4 |
4.048400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.590300E-02 |
| Normal-vs-ccB subtype |
3.764200E-01 |
| ccA subtype-vs-ccB subtype |
1.579280E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.462600E-01 |
| Normal-vs-N1 |
5.347400E-01 |
| N0-vs-N1 |
5.545600E-01 |
|
|
